| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 212,473 | 224,177 | 205,666 | 237,935 | | Cost of Revenue | 95,961 | 103,750 | 94,615 | 111,412 | | | Gross Profit | 116,512 | 120,427 | 111,051 | 126,523 | | | Operating Expenses | | Research Development | 11,016 | 11,275 | 10,261 | 10,623 | | Selling General and Administrative | 65,282 | 66,411 | 64,349 | 72,395 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,842 | 4,977 | 4,189 | 4,291 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 36,372 | 37,764 | 32,252 | 39,214 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 657 | (1,119) | 1,802 | 2,298 | | Earnings Before Interest And Taxes | 37,029 | 36,645 | 34,054 | 41,512 | | Interest Expense |
-
| 78 | 535 | 136 | | Income Before Tax | 37,029 | 36,567 | 33,519 | 41,376 | | Income Tax Expense | 12,034 | 12,143 | 9,888 | 14,068 | | Minority Interest | (224) | (435) | (279) | (234) | | | | Net Income From Continuing Ops | 24,771 | 23,989 | 23,352 | 27,074 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,771 | 23,989 | 23,352 | 27,074 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,771 | $23,989 | $23,352 | $27,074 |
|
0.51% Nasdaq 
Income Statement
